Mark Billone

Mark Billone is an experienced leader in the oncology and medical device sectors, currently serving as the Regional Business Director for Novocure since November 2024. Prior to this role, Mark held positions such as Regional Business Leader at Puma Biotechnology, Inc., and Vice President of Sales at Vanguard Medical, demonstrating a consistent focus on oncology and sales leadership. With a career spanning over two decades, Mark has held significant roles at AstraZeneca, Biogen, Bristol-Myers Squibb, NuVasive, Smith & Nephew/Bioventus, and Siemens Medical Solutions, where responsibilities have included building and managing sales teams, driving business growth, and supporting therapeutic products. Mark holds a Bachelor’s Degree in Finance from Bloomsburg University of Pennsylvania.